AI Drugmaker Wants Investor Suit Over Botched Trial Tossed
Artificial intelligence-based drugmaker BioXcel Therapeutics Inc. is urging a Connecticut federal court to drop a suit accusing it of failing to disclose stumbles that allegedly affected the integrity of a dementia...To view the full article, register now.
Already a subscriber? Click here to view full article